elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28677399-F5EAFBD9-92E2-4589-81D9-99CEA0D155AB
Q28677399-F5EAFBD9-92E2-4589-81D9-99CEA0D155AB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28677399-F5EAFBD9-92E2-4589-81D9-99CEA0D155AB
Innovative solutions to novel drug development in mental health
P2860
Q28677399-F5EAFBD9-92E2-4589-81D9-99CEA0D155AB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28677399-F5EAFBD9-92E2-4589-81D9-99CEA0D155AB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3e98fd2cb054d312dc26a559a65d3a0c16cf351a
P2860
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression